Published in PLoS One on June 09, 2009
X-ray-computed tomography contrast agents. Chem Rev (2012) 1.52
Tensor based multichannel reconstruction for breast tumours identification from DCE-MRIs. PLoS One (2017) 1.37
Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano (2012) 1.12
Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol (2011) 1.10
Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond) (2014) 1.07
Dual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study. PLoS One (2014) 1.06
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One (2009) 1.06
Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm (2013) 1.04
Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano (2012) 1.03
The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology (2011) 1.00
Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev (2014) 0.91
Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth. PLoS One (2012) 0.90
Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. ACS Nano (2013) 0.88
Alternative splicing of VEGFA, APP and NUMB genes in colorectal cancer. World J Gastroenterol (2015) 0.81
High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J (2012) 0.80
The biology of VEGF and its receptors. Nat Med (2003) 32.13
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science (2005) 23.44
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Angiogenesis as a therapeutic target. Nature (2005) 11.89
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging (1997) 6.77
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med (1991) 5.33
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res (2006) 4.43
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev (1999) 4.02
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res (2001) 3.48
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res (2002) 3.14
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol (2006) 3.12
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol (2006) 2.72
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem (2007) 2.67
Significance of blood vessel leakiness in cancer. Cancer Res (2002) 2.43
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr (1991) 2.34
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med (1990) 1.99
The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS (2005) 1.93
The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am (2001) 1.77
Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst (2005) 1.76
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev (2001) 1.63
The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci (2006) 1.63
Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist (2000) 1.61
Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur J Nucl Med Mol Imaging (2008) 1.55
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol (1998) 1.47
Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol (1996) 1.43
Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol (2001) 1.36
Adrenomedullin and tumour angiogenesis. Br J Cancer (2006) 1.27
Breast tumour angiogenesis. Breast Cancer Res (2007) 1.22
Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol (2006) 1.20
Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology (2009) 1.20
Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. Radiology (2008) 1.17
Models of breast cancer: quo vadis, animal modeling? Breast Cancer Res (2003) 1.10
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol (2001) 1.02
Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials (2008) 1.00
Quantitative PET imaging of VEGF receptor expression. Mol Imaging Biol (2008) 0.98
MRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat glioma. Nanotechnology (2008) 0.87
Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol (2008) 0.87
Contrast enhancement in dense breast images using the modulation transfer function. Med Phys (2002) 0.85
Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation. Lab Invest (2004) 0.85
Estimation of human tumor growth rate from distribution of tumor size at detection. J Natl Cancer Inst (1984) 0.85
Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model. J Oncol Pharm Pract (2007) 0.81
The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis. J Intern Med (2006) 0.80
Expression of VEGF and VEGFR2 in tumors during neoadjuvant therapy of patients with breast cancer. Bull Exp Biol Med (2008) 0.76
Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology (2008) 5.59
Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer. AJR Am J Roentgenol (2002) 2.78
International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst (2003) 2.75
The ACR BI-RADS experience: learning from history. J Am Coll Radiol (2009) 2.68
American College of Radiology Imaging Network digital mammographic imaging screening trial: objectives and methodology. Radiology (2005) 2.42
A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol (2006) 2.21
To seek perfection or not? That is the question. Radiology (2012) 2.15
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg Infect Dis (2011) 2.11
Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography. Radiology (2005) 1.87
The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps. Biomaterials (2008) 1.80
Implanted neural electrodes cause chronic, local inflammation that is correlated with local neurodegeneration. J Neural Eng (2009) 1.80
Topography, cell response, and nerve regeneration. Annu Rev Biomed Eng (2010) 1.70
Implanted neural interfaces: biochallenges and engineered solutions. Annu Rev Biomed Eng (2009) 1.67
Does training in the Breast Imaging Reporting and Data System (BI-RADS) improve biopsy recommendations or feature analysis agreement with experienced breast imagers at mammography? Radiology (2002) 1.63
Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A (2009) 1.48
Scatter radiation in digital tomosynthesis of the breast. Med Phys (2007) 1.46
In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials (2005) 1.45
Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res (2007) 1.44
Computational fluid dynamics simulation of airflow and aerosol deposition in human lungs. Ann Biomed Eng (2003) 1.34
CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol Cell Neurosci (2005) 1.32
Biomechanical analysis of silicon microelectrode-induced strain in the brain. J Neural Eng (2005) 1.31
Clinical digital breast tomosynthesis system: dosimetric characterization. Radiology (2012) 1.29
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release (2003) 1.27
Dosimetric characterization of a dedicated breast computed tomography clinical prototype. Med Phys (2010) 1.27
The impact of chronic blood-brain barrier breach on intracortical electrode function. Biomaterials (2013) 1.25
Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano (2011) 1.25
Reduced levels of membrane-bound alkaline phosphatase are common to lepidopteran strains resistant to Cry toxins from Bacillus thuringiensis. PLoS One (2011) 1.23
Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology (2009) 1.20
Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials (2012) 1.20
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release (2006) 1.19
Cupping artifact correction and automated classification for high-resolution dedicated breast CT images. Med Phys (2012) 1.19
The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. AJR Am J Roentgenol (2010) 1.18
Controlled release of anti-inflammatory agent alpha-MSH from neural implants. J Control Release (2005) 1.17
Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med (2006) 1.17
Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gaps. Biomaterials (2007) 1.15
Nanoscale neuro-integrative coatings for neural implants. Biomaterials (2005) 1.13
Evaluating imaging and computer-aided detection and diagnosis devices at the FDA. Acad Radiol (2012) 1.13
Community-based mammography practice: services, charges, and interpretation methods. AJR Am J Roentgenol (2005) 1.12
Radiologist uncertainty and the interpretation of screening. Med Decis Making (2004) 1.12
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. Sci Transl Med (2012) 1.12
Accuracy of soft-copy digital mammography versus that of screen-film mammography according to digital manufacturer: ACRIN DMIST retrospective multireader study. Radiology (2008) 1.10
Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol (2011) 1.10
Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials (2008) 1.09
Nanoscale laminin coating modulates cortical scarring response around implanted silicon microelectrode arrays. J Neural Eng (2006) 1.09
Biomaterials for the central nervous system. J R Soc Interface (2008) 1.08
Flat-panel digital mammography system: contrast-detail comparison between screen-film radiographs and hard-copy images. Radiology (2002) 1.08
Anisotropic scaffolds facilitate enhanced neurite extension in vitro. J Biomed Mater Res A (2006) 1.07
Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. Tissue Eng (2003) 1.06
The association between obesity and screening mammography accuracy. Arch Intern Med (2004) 1.06
Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials (2009) 1.06
Monte Carlo and phantom study of the radiation dose to the body from dedicated CT of the breast. Radiology (2008) 1.06
Glandular radiation dose in tomosynthesis of the breast using tungsten targets. J Appl Clin Med Phys (2008) 1.05
Thin-film enhanced nerve guidance channels for peripheral nerve repair. Biomaterials (2009) 1.04
Extraction force and cortical tissue reaction of silicon microelectrode arrays implanted in the rat brain. IEEE Trans Biomed Eng (2007) 1.04
Folate targeting of drug carriers: a mathematical model. J Control Release (2005) 1.04
Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury. Biomaterials (2009) 1.03
Relationship between intracortical electrode design and chronic recording function. Biomaterials (2013) 1.03
Mammographers' perception of women's breast cancer risk. Med Decis Making (2005) 1.03
The upregulation of specific interleukin (IL) receptor antagonists and paradoxical enhancement of neuronal apoptosis due to electrode induced strain and brain micromotion. Biomaterials (2012) 1.01
Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials (2008) 1.00
Automatic Tissue Classification for High-resolution Breast CT Images Based on Bilateral Filtering. Proc SPIE Int Soc Opt Eng (2011) 1.00
Role of fibronectin in topographical guidance of neurite extension on electrospun fibers. Biomaterials (2011) 0.96
Sustained release of plasmid DNA using lipid microtubules and agarose hydrogel. J Control Release (2003) 0.96
Modulation of Rho GTPase activity alleviates chondroitin sulfate proteoglycan-dependent inhibition of neurite extension. J Neurosci Res (2004) 0.95
Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol (2010) 0.95
Dedicated breast computed tomography: the optimal cross-sectional imaging solution? Radiol Clin North Am (2010) 0.95
Sustained release of BMP-2 in a lipid-based microtube vehicle. Acta Biomater (2008) 0.94
Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. Acad Radiol (2003) 0.94
Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Control Release (2004) 0.93
Detection of simulated lesions on data-compressed digital mammograms. Radiology (2005) 0.92
Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J Control Release (2003) 0.91
Detection of simulated microcalcifications in a phantom with digital mammography: effect of pixel size. Radiology (2007) 0.91
A software-based x-ray scatter correction method for breast tomosynthesis. Med Phys (2011) 0.90
Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism. Cancer Res (2012) 0.90
A perceptual evaluation of JPEG 2000 image compression for digital mammography: contrast-detail characteristics. J Digit Imaging (2004) 0.89
A perspective on immunomodulation and tissue repair. Ann Biomed Eng (2013) 0.89
Stereoscopic digital mammography: improved specificity and reduced rate of recall in a prospective clinical trial. Radiology (2012) 0.89
Digital mammography. Radiol Clin North Am (2004) 0.88
Ten simple rules for cultivating open science and collaborative R&D. PLoS Comput Biol (2013) 0.88
Breast arterial calcification: a marker of medial vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.88
Regenerative scaffold electrodes for peripheral nerve interfacing. IEEE Trans Neural Syst Rehabil Eng (2012) 0.88
MRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat glioma. Nanotechnology (2008) 0.87
Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study. Radiology (2007) 0.87